Law.com has the story -- do go read it all -- but I will say that this one (a couple of my several backgrounders -- here, and here) has a high probabilty of ultimately ending in Glenmark's favor:
. . . .A generic drug maker hoping to sell its own version of the popular cholesterol drug Zetia® has succeeded in knocking out part of Schering-Plough Corp.'s patent protection on the medication. . . .
The ruling came in Schering Corp. v. Glenmark Pharmaceuticals , 07-cv-1334, an infringement suit that Schering filed in March 2007, shortly after Glenmark asked the Food and Drug Administration for approval to market a generic version of Zetia.
Though granted partial summary judgment on the issue, Glenmark still faces allegations that it infringed the earlier patent, which contains claims broader than those added in 2002. . . .
Full $17.8 billion New Merck patent-cliff table, here.
No comments:
Post a Comment